<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250313065062N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-05</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of adding massage gun before or after dry needling versus dry needling alone on hamstring flexibility, strength and performance, and post-needling soreness in male amateur bodybuilders with hamstring shortness</public_title>
      <acronym></acronym>
      <scientific_title>Effects of adding massage gun before or after dry needling versus dry needling alone on hamstring flexibility, strength and performance, and post-needling soreness in male amateur bodybuilders with hamstring shortness</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-05-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/82900</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be performed using Block Randomization and allocation concealment will be done using sequentially numbered, opaque, sealed envelopes. This method is one of the common methods of concealing random allocation, which is known as the SNOSE method for short. The random allocation process will be performed by someone outside the research team before the study begins. Finally, each individual's study group assignment will be determined according to the contents of the envelope provided to them. Accordingly, individuals will be divided into three groups: dry needling alone, dry needling with percussion massage before, and dry needling with percussion massage after, Blinding description: A trained physiotherapist, blinded to group allocation, recorded participant characteristics including age, weight, and height and measured study variables before, immediately after, and 24 hours after the intervention. Another experienced physiotherapist performed the interventions on the dominant leg of the individual with hamstring shortening.</study_design>
      <phase>N/A</phase>
      <hc_freetext>hamstring shortness.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Dry needling ، A physiotherapist will use sterile disposable needles (Eacu brand, Korea) for dry needling, using hygienic measures such as wearing gloves and using alcohol to disinfect the site and gloves, and then the used needles will be placed in the Safety Box. During a session, participants will be needled at three points on the hamstrings for 1 minute using the fast in–out cone-shaped technique in the prone position. Two points on the short and long heads of the biceps femoris muscle will be needled at 60% and 30% of the distance from the ischial tuberosity to the fibular head, respectively. The third point targets the semimembranosus and semitendinosus muscles at 60% of the distance from the ischial tuberosity to the medial femoral epicondyle. Intervention 2: Intervention group 1: Dry needling followed by percussion massage intervention, percussion massage intervention: Percussion massage is applied to the hamstring muscle for 5 minutes with a Booster Lightstaber (china) massage device at a speed of 3200 revolutions per minute (rpm) equivalent to a frequency of 53 Hz with a “hard ball” head. The semimembranosus and semitendinosus muscles are massaged in the first 2.5 minutes of massage and the biceps femoris muscle in the second 2.5 minutes. In the first 2.5 minutes, the massage begins from the inner side of the muscle, focusing on applying equal pressure throughout the massage. The massage is performed by moving the device from distal to proximal and from proximal to distal in a straight line for 20 seconds. In the last 2.5 minutes, the massage device is moved outward at the distal end of the muscle and the application is performed from distal to proximal and then distal. In this way, the massage for each muscle starts from the inside and ends on the outside. Intervention 3: Intervention group 2: Dry needling and before that, percussion massage intervention, percussion massage intervention: Percussion massage is applied to the hamstring muscle for 5 minutes with a Booster Lightstaber (china) massage device at a speed of 3200 revolutions per minute (rpm) equivalent to a frequency of 53 Hz with a "hard ball" head. The semimembranosus and semitendinosus muscles are massaged in the first 2.5 minutes of massage and the biceps femoris muscle in the second 2.5 minutes. In the first 2.5 minutes, the massage begins from the inner side of the muscle, focusing on applying equal pressure throughout the massage. The massage is performed by moving the device from distal to proximal and from proximal to distal in a straight line for 20 seconds. In the last 2.5 minutes, the massage device is moved outward at the distal end of the muscle and the application is performed from distal to proximal and then distal. In this way, the massage for each muscle starts from the inside and ends on the outside.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is ...</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohsen Ghoorchibeigi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran medical University dormitory for men , affront of 16th Street of kargar shomali , amirabad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439955975</zip>
        <telephone>+98 21 8835 2176</telephone>
        <email>mohsenghoorchibeigi@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Kazem Malmir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab St., Pich shemiran , Corner of Safi Alishah St., Faculty of Rehabilitation</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7753 3939</telephone>
        <email>kmalmir@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male amateur bodybuilders with at least three two-hour training sessions per week
Age range 18 to 40 years
Hamstring shortening ≥20 degrees in the dominant leg, determined by active knee extension testing
Body mass index (BMI) between 18.5 and 29.9 kg/m2</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Use of nonsteroidal anti-inflammatory drugs, analgesics, or muscle relaxants during the study period
Having any contraindications for dry needling, including, medical emergency or acute medical condition, local infection, lymphedema, coagulation disorders such as hemophilia, epilepsy, metal sensitivity (dry needling)
Having any contraindications for percussive massage, including varicose veins, broken bones, areas with blood clots
Back pain or radicular pain within the past 3 months
History of back, hip, or knee surgery within the past year
of hamstring strain within the past 3 months
History of orthopedic or neurological diseases in the lower extremities</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Dry needling ، A physiotherapist will use sterile disposable needles (Eacu brand, Korea) for dry needling, using hygienic measures such as wearing gloves and using alcohol to disinfect the site and gloves, and then the used needles will be placed in the Safety Box. During a session, participants will be needled at three points on the hamstrings for 1 minute using the fast in–out cone-shaped technique in the prone position. Two points on the short and long heads of the biceps femoris muscle will be needled at 60% and 30% of the distance from the ischial tuberosity to the fibular head, respectively. The third point targets the semimembranosus and semitendinosus muscles at 60% of the distance from the ischial tuberosity to the medial femoral epicondyle.</i_keyword>
      <i_keyword>Intervention group 1: Dry needling followed by percussion massage intervention, percussion massage intervention: Percussion massage is applied to the hamstring muscle for 5 minutes with a Booster Lightstaber (china) massage device at a speed of 3200 revolutions per minute (rpm) equivalent to a frequency of 53 Hz with a “hard ball” head. The semimembranosus and semitendinosus muscles are massaged in the first 2.5 minutes of massage and the biceps femoris muscle in the second 2.5 minutes. In the first 2.5 minutes, the massage begins from the inner side of the muscle, focusing on applying equal pressure throughout the massage. The massage is performed by moving the device from distal to proximal and from proximal to distal in a straight line for 20 seconds. In the last 2.5 minutes, the massage device is moved outward at the distal end of the muscle and the application is performed from distal to proximal and then distal. In this way, the massage for each muscle starts from the inside and ends on the outside.</i_keyword>
      <i_keyword>Intervention group 2: Dry needling and before that, percussion massage intervention, percussion massage intervention: Percussion massage is applied to the hamstring muscle for 5 minutes with a Booster Lightstaber (china) massage device at a speed of 3200 revolutions per minute (rpm) equivalent to a frequency of 53 Hz with a "hard ball" head. The semimembranosus and semitendinosus muscles are massaged in the first 2.5 minutes of massage and the biceps femoris muscle in the second 2.5 minutes. In the first 2.5 minutes, the massage begins from the inner side of the muscle, focusing on applying equal pressure throughout the massage. The massage is performed by moving the device from distal to proximal and from proximal to distal in a straight line for 20 seconds. In the last 2.5 minutes, the massage device is moved outward at the distal end of the muscle and the application is performed from distal to proximal and then distal. In this way, the massage for each muscle starts from the inside and ends on the outside.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Hamstring muscle flexibility. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: With goniometer in active knee extension test 90/90.</prim_outcome>
      <prim_outcome>Hamstring stretch tolerance angle degree. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: With goniometer in active knee extension test 90/90.</prim_outcome>
      <prim_outcome>Maximum hamstring strength in isometric contraction at 45 and 60 degree knee angles. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: Dynamometer.</prim_outcome>
      <prim_outcome>Hamstring to quadriceps contraction ratio at 45 and 60 degree knee angles. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: Dynamometer and ratio formula.</prim_outcome>
      <prim_outcome>Performance. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: Triple hop test.</prim_outcome>
      <prim_outcome>Dry needling soreness. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: Numerical pain rating scale.</prim_outcome>
      <prim_outcome>Pressure pain threshold. Timepoint: Before the intervention, immediately after the intervention, and 24 hours after the intervention. Method of measurement: Algometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-03-11</approval_date>
        <contact_name>Ethics Committee of the Faculty of Nursing and Midwifery and the Faculty of Rehabilitation - Tehran </contact_name>
        <contact_address>Shahrak Qods (West), between South Flamack and Zarafshan, Simay Iran Street - Central Headquarters of the Ministry of Health, Treatment and Medical Education, Block A, 13th Floor Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
